Sign Up to like & get
recommendations!
0
Published in 2021 at "Sleep"
DOI: 10.1093/sleep/zsab200
Abstract: STUDY OBJECTIVES To assess the efficacy and safety of FT218, a novel once-nightly formulation of sodium oxybate (ON-SXB), in patients with narcolepsy in the phase 3 REST-ON trial. METHODS Narcolepsy patients aged ≥16 years were…
read more here.
Keywords:
improvement;
sxb;
ft218;
sodium oxybate ... See more keywords
Sign Up to like & get
recommendations!
3
Published in 2023 at "SLEEP"
DOI: 10.1093/sleep/zsad077.0579
Abstract: The pivotal phase 3 REST-ON trial (NCT02720744) evaluated the efficacy and safety of once-nightly sodium oxybate (ON-SXB; FT218), an investigational extended-release formulation for treatment of adults with narcolepsy. In REST-ON, ON-SXB met its 3 coprimary…
read more here.
Keywords:
safety;
oxybate;
sxb;
restore study ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Sleep"
DOI: 10.1093/sleep/zsad103
Abstract: STUDY OBJECTIVES Symptomatic therapies for REM sleep behavior disorder (RBD) are limited. Sodium oxybate (SXB), a gamma-aminobutyric acid (GABA)-B agonist, could be effective but has not been evaluated against placebo. METHODS This double-blind, parallel-group, randomized,…
read more here.
Keywords:
sleep behavior;
rbd;
behavior disorder;
rem sleep ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Sleep"
DOI: 10.1093/sleep/zsad135
Abstract: Longterm use of sodium oxybate (SXB), (also called gamma-hydroxybutyrate (GHB)) attenuates the cataplexy and sleepiness of human narcolepsy. We had previously found that chronic opiate usage in humans and longterm opiate administration to mice significantly…
read more here.
Keywords:
sodium oxybate;
hypocretin orexin;
locus coeruleus;
sxb ... See more keywords